Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral salmon calcitonin for knee osteoarthritis
2007-003016-60Phase 3Completed
- Sponsor
- Nordic Bioscience
- Start
- Sep 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Oral salmon calcitonin with Placebo (2 arms). Primary endpoint: Joint space width of medial tibio-femoral knee joint. Started Sep 2007; status: completed.
02
Drugs
calcitonin salmon
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2007-003016-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003016-60.